Click for best price
Precision Cancer Therapies Market Size, Share 2023
Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Therapies. This report contains market size and forecasts of Precision Cancer Therapies in global, including the following market information:
Global Precision Cancer Therapies Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Precision Cancer Therapies market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in the tumor?s genome.
We surveyed the Precision Cancer Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Precision Cancer Therapies Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Precision Cancer Therapies Market Segment Percentages, by Type, 2022 (%)
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy
Global Precision Cancer Therapies Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Precision Cancer Therapies Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes
Global Precision Cancer Therapies Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Precision Cancer Therapies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Precision Cancer Therapies revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Precision Cancer Therapies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Precision Cancer Therapies, market overview.
Chapter 2: Global Precision Cancer Therapies market size in revenue.
Chapter 3: Detailed analysis of Precision Cancer Therapies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Precision Cancer Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Precision Cancer Therapies Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Precision Cancer Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Therapies Overall Market Size
2.1 Global Precision Cancer Therapies Market Size: 2022 VS 2030
2.2 Global Precision Cancer Therapies Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Therapies Players in Global Market
3.2 Top Global Precision Cancer Therapies Companies Ranked by Revenue
3.3 Global Precision Cancer Therapies Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Therapies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Precision Cancer Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Therapies Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Precision Cancer Therapies Market Size Markets, 2022 & 2030
4.1.2 Hormone Therapy
4.1.3 Immunotherapies
4.1.4 Targeted Therapy
4.1.5 Monoclonal Antibody Therapy
4.1.6 Gene Therapy
4.2 By Type - Global Precision Cancer Therapies Revenue & Forecasts
4.2.1 By Type - Global Precision Cancer Therapies Revenue, 2018-2023
4.2.2 By Type - Global Precision Cancer Therapies Revenue, 2024-2030
4.2.3 By Type - Global Precision Cancer Therapies Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precision Cancer Therapies Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Diagnostic Centers
5.1.4 Oncology Clinics
5.1.5 Research Institutes
5.2 By Application - Global Precision Cancer Therapies Revenue & Forecasts
5.2.1 By Application - Global Precision Cancer Therapies Revenue, 2018-2023
5.2.2 By Application - Global Precision Cancer Therapies Revenue, 2024-2030
5.2.3 By Application - Global Precision Cancer Therapies Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Precision Cancer Therapies Market Size, 2022 & 2030
6.2 By Region - Global Precision Cancer Therapies Revenue & Forecasts
6.2.1 By Region - Global Precision Cancer Therapies Revenue, 2018-2023
6.2.2 By Region - Global Precision Cancer Therapies Revenue, 2024-2030
6.2.3 By Region - Global Precision Cancer Therapies Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Precision Cancer Therapies Revenue, 2018-2030
6.3.2 US Precision Cancer Therapies Market Size, 2018-2030
6.3.3 Canada Precision Cancer Therapies Market Size, 2018-2030
6.3.4 Mexico Precision Cancer Therapies Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Precision Cancer Therapies Revenue, 2018-2030
6.4.2 Germany Precision Cancer Therapies Market Size, 2018-2030
6.4.3 France Precision Cancer Therapies Market Size, 2018-2030
6.4.4 U.K. Precision Cancer Therapies Market Size, 2018-2030
6.4.5 Italy Precision Cancer Therapies Market Size, 2018-2030
6.4.6 Russia Precision Cancer Therapies Market Size, 2018-2030
6.4.7 Nordic Countries Precision Cancer Therapies Market Size, 2018-2030
6.4.8 Benelux Precision Cancer Therapies Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Precision Cancer Therapies Revenue, 2018-2030
6.5.2 China Precision Cancer Therapies Market Size, 2018-2030
6.5.3 Japan Precision Cancer Therapies Market Size, 2018-2030
6.5.4 South Korea Precision Cancer Therapies Market Size, 2018-2030
6.5.5 Southeast Asia Precision Cancer Therapies Market Size, 2018-2030
6.5.6 India Precision Cancer Therapies Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Precision Cancer Therapies Revenue, 2018-2030
6.6.2 Brazil Precision Cancer Therapies Market Size, 2018-2030
6.6.3 Argentina Precision Cancer Therapies Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precision Cancer Therapies Revenue, 2018-2030
6.7.2 Turkey Precision Cancer Therapies Market Size, 2018-2030
6.7.3 Israel Precision Cancer Therapies Market Size, 2018-2030
6.7.4 Saudi Arabia Precision Cancer Therapies Market Size, 2018-2030
6.7.5 UAE Precision Cancer Therapies Market Size, 2018-2030
7 Precision Cancer Therapies Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Precision Cancer Therapies Major Product Offerings
7.1.4 Abbott Laboratories Precision Cancer Therapies Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Bayer HealthCare
7.2.1 Bayer HealthCare Company Summary
7.2.2 Bayer HealthCare Business Overview
7.2.3 Bayer HealthCare Precision Cancer Therapies Major Product Offerings
7.2.4 Bayer HealthCare Precision Cancer Therapies Revenue in Global Market (2018-2023)
7.2.5 Bayer HealthCare Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Precision Cancer Therapies Major Product Offerings
7.3.4 GlaxoSmithKline Precision Cancer Therapies Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 OncoGenex Pharmaceuticals
7.4.1 OncoGenex Pharmaceuticals Company Summary
7.4.2 OncoGenex Pharmaceuticals Business Overview
7.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Major Product Offerings
7.4.4 OncoGenex Pharmaceuticals Precision Cancer Therapies Revenue in Global Market (2018-2023)
7.4.5 OncoGenex Pharmaceuticals Key News & Latest Developments
7.5 Hospira
7.5.1 Hospira Company Summary
7.5.2 Hospira Business Overview
7.5.3 Hospira Precision Cancer Therapies Major Product Offerings
7.5.4 Hospira Precision Cancer Therapies Revenue in Global Market (2018-2023)
7.5.5 Hospira Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Precision Cancer Therapies Major Product Offerings
7.6.4 Boehringer Ingelheim Precision Cancer Therapies Revenue in Global Market (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Precision Cancer Therapies Major Product Offerings
7.7.4 AstraZeneca Precision Cancer Therapies Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Aveo Pharmaceuticals
7.8.1 Aveo Pharmaceuticals Company Summary
7.8.2 Aveo Pharmaceuticals Business Overview
7.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Major Product Offerings
7.8.4 Aveo Pharmaceuticals Precision Cancer Therapies Revenue in Global Market (2018-2023)
7.8.5 Aveo Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Precision Cancer Therapies Market Opportunities & Trends in Global Market
Table 2. Precision Cancer Therapies Market Drivers in Global Market
Table 3. Precision Cancer Therapies Market Restraints in Global Market
Table 4. Key Players of Precision Cancer Therapies in Global Market
Table 5. Top Precision Cancer Therapies Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Precision Cancer Therapies Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Precision Cancer Therapies Revenue Share by Companies, 2018-2023
Table 8. Global Companies Precision Cancer Therapies Product Type
Table 9. List of Global Tier 1 Precision Cancer Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precision Cancer Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Precision Cancer Therapies Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Precision Cancer Therapies Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Precision Cancer Therapies Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Precision Cancer Therapies Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Precision Cancer Therapies Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Precision Cancer Therapies Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Precision Cancer Therapies Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Precision Cancer Therapies Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Precision Cancer Therapies Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Precision Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Precision Cancer Therapies Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Precision Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Precision Cancer Therapies Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Precision Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Precision Cancer Therapies Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Precision Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Precision Cancer Therapies Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Precision Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Precision Cancer Therapies Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Precision Cancer Therapies Product Offerings
Table 32. Abbott Laboratories Precision Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Bayer HealthCare Company Summary
Table 35. Bayer HealthCare Precision Cancer Therapies Product Offerings
Table 36. Bayer HealthCare Precision Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer HealthCare Key News & Latest Developments
Table 38. GlaxoSmithKline Company Summary
Table 39. GlaxoSmithKline Precision Cancer Therapies Product Offerings
Table 40. GlaxoSmithKline Precision Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Key News & Latest Developments
Table 42. OncoGenex Pharmaceuticals Company Summary
Table 43. OncoGenex Pharmaceuticals Precision Cancer Therapies Product Offerings
Table 44. OncoGenex Pharmaceuticals Precision Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 45. OncoGenex Pharmaceuticals Key News & Latest Developments
Table 46. Hospira Company Summary
Table 47. Hospira Precision Cancer Therapies Product Offerings
Table 48. Hospira Precision Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 49. Hospira Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Precision Cancer Therapies Product Offerings
Table 52. Boehringer Ingelheim Precision Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Precision Cancer Therapies Product Offerings
Table 56. AstraZeneca Precision Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Aveo Pharmaceuticals Company Summary
Table 59. Aveo Pharmaceuticals Precision Cancer Therapies Product Offerings
Table 60. Aveo Pharmaceuticals Precision Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 61. Aveo Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Precision Cancer Therapies Segment by Type in 2022
Figure 2. Precision Cancer Therapies Segment by Application in 2022
Figure 3. Global Precision Cancer Therapies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Precision Cancer Therapies Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Precision Cancer Therapies Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precision Cancer Therapies Revenue in 2022
Figure 8. By Type - Global Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 9. By Application - Global Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 10. By Type - Global Precision Cancer Therapies Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 12. By Application - Global Precision Cancer Therapies Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 14. By Region - Global Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 15. By Country - North America Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 16. US Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 20. Germany Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 21. France Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 28. China Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 32. India Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 34. Brazil Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Precision Cancer Therapies Revenue Market Share, 2018-2030
Figure 37. Turkey Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Precision Cancer Therapies Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Laboratories Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer HealthCare Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. OncoGenex Pharmaceuticals Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hospira Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Boehringer Ingelheim Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Aveo Pharmaceuticals Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
